Aurora Cannabis Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Aurora Cannabis hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

n/a

Ausschüttungsquote

Durchschnittlicher Branchenertrag	2.2%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Gewinn pro Aktie	-CA$1.01
Erwartete Dividendenrendite in 3 Jahren	0%

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term

Nov 13

Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?

Sep 22

Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt

Apr 21

Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?

Jan 05

A Look At The Intrinsic Value Of Aurora Cannabis Inc. (TSE:ACB)

Nov 13

Is Aurora Cannabis (TSE:ACB) Weighed On By Its Debt Load?

Oct 04

Aurora Cannabis Inc. (TSE:ACB) Shares Could Be 46% Below Their Intrinsic Value Estimate

Aug 10

Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?

Jul 06

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von ACB in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von ACB gestiegen sind.

Dividendenrendite im Vergleich zum Markt

Aurora Cannabis Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von ACB im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (ACB)	n/a
Untere 25 % des Marktes (CA)	1.8%
Markt Top 25 % (CA)	6.5%
Branchendurchschnitt (Pharmaceuticals)	2.2%
Analystenprognose in 3 Jahren (ACB)	0%

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von ACB im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von ACB im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von ACB, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da ACB keine Ausschüttungen gemeldet hat.

Aurora Cannabis Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

Recent updates

Full year 2024 earnings released: CA$1.28 loss per share (vs CA$8.22 loss in FY 2023)

Forecast breakeven date pushed back to 2027

Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors

Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products

New minor risk - Share price stability

Consensus EPS estimates upgraded to CA$1.44 loss

Price target increased by 62% to CA$16.58

Aurora Cannabis Inc. Announces CFO Changes

Why Aurora Cannabis' (TSE:ACB) Earnings Are Weaker Than They Seem

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Shareholder dilution

New minor risk - Profitability

Consensus EPS estimates fall by 48%, revenue upgraded

Aurora Cannabis Inc. (TSX:ACB) acquired remaining 90% stake in Indica Industries Pty Ltd for AUD 45 million.

Aurora Cannabis Inc. Provides Earnings Guidance for the Fourth Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q3, 2024 Results on Feb 08, 2024

Forecast to breakeven in 2026

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for Third Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q2, 2024 Results on Nov 09, 2023

New major risk - Shareholder dilution

Insider exercised options and sold CA$62k worth of stock

Aurora Cannabis Inc. has completed a Follow-on Equity Offering in the amount of CAD 38.826875 million.

Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?

Price target decreased by 27% to CA$0.96

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024

Aurora Cannabis Inc. to Report Q1, 2024 Results on Aug 10, 2023

Bevo Farms Ltd acquired Medicine Hat, Alberta Aurora Sun Facility from Aurora Cannabis Inc. (TSX:ACB) for CAD 15 million.

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

CEO & Director recently bought CA$131k worth of stock

New minor risk - Profitability

Consensus EPS estimates upgraded to CA$0.16 loss, revenue downgraded

Price target decreased by 20% to CA$1.49

Price target decreased by 10% to CA$1.75

Investors Holding Back On Aurora Cannabis Inc. (TSE:ACB)

Aurora Cannabis Inc. to Report Fiscal Year 2023 Results on Jun 14, 2023

Aurora Celebrates Summer with New Innovation Launching Across Canada

Aurora Cannabis Inc., Annual General Meeting, Aug 14, 2023

Forecast to breakeven in 2026

Aurora Cannabis Inc. Reports Impairment Changes for the Quarter Ended December 31, 2022

Price target decreased by 10% to CA$2.05

Second quarter 2023 earnings released

Aurora Cannabis Inc. to Report Q2, 2023 Results on Feb 09, 2023

Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD15 million.

Now 22% undervalued after recent price drop

Consensus revenue estimates fall by 14%

Forecast to breakeven in 2025

Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term

First quarter 2023 earnings released: CA$0.17 loss per share (vs CA$0.06 loss in 1Q 2022)

Aurora Cannabis Inc. to Report Q1, 2023 Results on Nov 10, 2022

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Consensus forecasts updated

Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?

Full year 2022 earnings: Revenues in line with analyst expectations

Price target decreased to CA$3.07

Aurora Cannabis Inc. to Report Q4, 2022 Results on Sep 20, 2022

Aurora Cannabis Inc., Annual General Meeting, Nov 14, 2022

Aurora Cannabis Inc. (TSX:ACB) acquired 50.1% stake in Bevo Agtech Inc. for CAD 57 million.

Independent Director recently bought CA$84k worth of stock

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $150.00125 million.

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $125.195 million.

Consensus EPS estimates fall by 397%

Aurora Cannabis Inc. Reports Impairment Chargers for the Three Months Ended March 31, 2022

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Aurora Cannabis Inc. (TSX:ACB) completed the acquisition of TerraFarma, Inc. for CAD 38 million.

Aurora Cannabis Inc. to Report Q3, 2022 Results on May 12, 2022

Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt

High number of new directors

Consensus EPS estimates fall by 57%

An unknown buyer entered into an asset purchase agreement to acquire Nordic Sky Production Facility located in Denmark from Aurora Cannabis Inc. (TSX:ACB) for CAD 7.5 million.

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations